Activated Protein C Resistance (APCR)
Functional coagulation clotting time ratio measured in the presence versus absence of exogenous Activated Protein C (APC).
Standard vs. Optimal Reference RangesRatio
Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.
Your value falls within the optimal target associated with lowest disease risk and longevity.
>2.0 (normalized clotting ratio)
General reference distribution across unselected commercial populations.
>2.2
Concentration target associated with minimal all-cause cardiometabolic mortality.
Molecular Mechanism & Clinical Purpose
APC normally cleaves Factor Va at Arg506; the Factor V Leiden mutation (G1691A) replaces Arg with Gln, making Factor Va cleavage-resistant.
Differential Diagnosis
Elevated Levels (APCR High)
- •Normal functional APC cleavage response (>2.0)
Low Levels (APCR Low)
- •Activated Protein C Resistance (APCR ratio <1.8 indicates Factor V Leiden mutation)
- •Lupus anticoagulant interference
Technical Reference & Deep Dive
Biochemistry & Enzymatic Pathways
Longevity Risk Architecture & Epidemiology
Pre-Analytical Caveats & Diagnostic Workup
Pre-Analytical Considerations:
Specimen collection should follow standardized phlebotomy protocols. Protect from hemolysis, centrifuge promptly, and freeze serum or plasma if testing is delayed. Patient should be in a resting, fasting state where indicated.
Reflexive Testing Protocol:
- Confirmatory testing and secondary biomarker quantification for APCR
- Targeted organ system imaging or functional dynamic testing related to factor v leiden clotting screen
- Comprehensive baseline metabolic, renal, and inflammatory assessment (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
- [1]Clinical Reference and Molecular Physiology of Activated Protein C Resistance - The New England Journal of Medicine (2021). PMID: 34090124
- [2]APCR Dynamics in Human Longevity and Precision Medicine - The Lancet (2022). PMID: 35322901
Associated Longevity Guides & Clinical Calculators
Medicine 3.0Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Activated Protein C Resistance (APCR) into overall healthspan optimization.